Key facts
- It has raised $2.3M; the latest was Early Stage VC ($1.2M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, MedTech Innovator, VentureWell, New York Angels, Michigan Rise — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Entirety Biomedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Entirety Biomedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Entirety Biomedical
Manufacturer of high-performance absorbable metal implants intended to improve the quality of life with advanced bioabsorbable implant technology. The company facilitates the use of proprietary alloy technology to safely minimize implant life post-healing, provide simple and confident implantation, and ensure safe absorbability without increased risks of long-term complications, enabling patients to have a better life after implant while reducing surgical interventions and healthcare costs.
- Sector
- Healthcare
- HQ
- East Lansing, MI, United States
- Founded
- 2022
- Employees
- 6
- Website
- entiretybio.com/
- Ownership
- Privately Held (backing)
Entirety Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Entirety Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Entirety Biomedical in its N-PORT filings yet. We sweep new filings monthly.